AVAI BIO, INC. reports zero revenue and a going-concern warning for the quarter ended September 30, 2026.
SEC EDGAR, 2026-11-13: 10-Q — "substantial doubt"
AVAI BIO, INC. reports zero revenue and a going-concern warning for the quarter ended September 30, 2026.
Company: AVAI BIO, INC. (AVAI) Filed: 2026-11-13, 10-Q (Item none) Phrase: "substantial doubt" — "Therefore, there is substantial doubt about the Company’s ability to continue as a going concern." What the filing says: The company reported recurring losses and an accumulated deficit of $6,673,300 as of September 30, 2026. It has generated zero revenue for the three and six months ended September 30, 2026, and has not established a stabilized source of revenue to cover operating costs. The company had cash of $121,948 and total current liabilities of $4,534,882 as of September 30, 2026, and is dependent on additional investment capital to fund its operating expenses. Two ways it goes: A. The company secures additional investment capital through the capital markets or joint ventures to fund its operations. B. The company fails to obtain further funding and is unable to meet its operating and capital expenses. Next date: none named Watch: The filing of subsequent quarterly reports showing new capital raises or the generation of revenue. Tags: going concern